
Keywords: APIs; active pharmaceutical ingredients; LLMICs; low and low-middle income countries; DUW; direct discharge of untreated wastewater; DF; dilution factor; CBZ; carbamazepine; ACT; acetaminophen; NVR; nevirapine; DCF; diclofenac; VLS; valsartan; ACE; acebut